Evidence map›Paper›PMID 31753883›Full record

Observational studyBMJ open2019

Observational cohort study to investigate the unmet need and time waiting for referral for specialist opinion in adult asthma in England (UNTWIST asthma).

John D Blakey, Alicia Gayle, Mariel G Slater, Gareth H Jones, Michael Baldwin

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. The use of precision medicine for asthma.Frontiers in medicine · 2025
    Article
  4. Article
  5. The Path to Diagnosis of Severe Asthma-A Qualitative Exploration.International journal of general medicine · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

John D BlakeyRespiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
Alicia GayleMarket Access, Boehringer Ingelheim Ltd, Bracknell, UK.
Mariel G SlaterMedical Affairs, Boehringer Ingelheim Ltd, Bracknell, UK mariel.slater@boehringer-ingelheim.com.ORCID 0000-0003-0988-6146
Gareth H JonesDepartment of Respiratory Medicine, Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, UK.
Michael BaldwinTA Respiratory/Biosimilars, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Boehringer Ingelheim (United Kingdom) · GBBoehringer Ingelheim (Germany) · DERoyal Liverpool and Broadgreen University Hospital NHS Trust · GBUniversity of Liverpool · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aimed to estimate how many patients with asthma in England met the referral eligibility criteria using national asthma guidelines, identify what proportion were referred and determine the average waiting time to referral.

designThis is an observational cohort study. SETTING/DATA SOURCES: Routinely collected healthcare data were provided by Clinical Practice Research Datalink records and Hospital Episode Statistics records from January 2007 to December 2015.

participantsPatients with asthma aged 18-80 years participated in this study.

main outcome measuresEligibility for referral by the British Thoracic Society/Scottish Intercollegiate Guidelines Network (BTS/SIGN) 2016 guidelines, determined after a 3-month pharmacological therapy exposure assessment, was classed by either 'high-dose therapies', 'continuous or frequent use of oral steroids' or 'incident eligibility' during follow-up (continuous oral corticosteroids for more than 3 months, or ≥800 µg/day inhaled corticosteroids/long-acting β

resultsFrom the final cohort (n=23293), 19837 patients were eligible for specialist referral during follow-up based on the BTS/SIGN guideline recommendations. Among eligible patients without any previously recorded referral, 4% were referred during follow-up, with a median waiting time of 880 days (IQR=1428 days) between eligibility and referral.

conclusionsA large number of patients with asthma were eligible for specialist referral, of which a small proportion were referred, and many experienced a long waiting time before referral. The results indicate a major unmet need in asthma referral, which is a potential source of preventable harm and are likely to have implications regarding how services are organised to address this unmet need.

Indexed as

AdolescentAdrenal Cortex HormonesAdultAgedAged, 80 and overAsthmaCohort StudiesEnglandFemaleHealth Services AccessibilityHealth Services Needs and DemandHumansMaleMiddle AgedReferral and ConsultationTime FactorsAdrenal Cortex Hormonesasthmaobservationalreferralspecialistwait time

Identifiers

PMID31753883
PMCPMC6887034
OpenAlexW2990919173

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.